Allspring Global Investments
AERI

Allspring Global Investments’s Aerie Pharmaceuticals AERI Stock Holding History

Allspring Global Investments’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-35,952
Closed -$543K – 2980
2022
Q3 		$543K Sell
35,952
-398
-1% -$4.63K ﹤0.01% 1564
2022
Q2 		$272K Buy
36,350
+11,461
+46% +$80.8K ﹤0.01% 1734
2022
Q1 		$226K Sell
24,889
-27,674
-53% -$213K ﹤0.01% 2533
2021
Q4 		$368K Buy
+52,563
New +$550K ﹤0.01% 2426

Allspring Global Investments's AERI Position: Q4 2022 in Review

Allspring Global Investments sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 35,952 shares — an estimated $543K sold.

Allspring Global Investments first reported a position in AERI in Q4 2021 and held it in 4 quarters. The position peaked at $543K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Allspring Global Investments reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Allspring Global Investments sold 35,952 Aerie Pharmaceuticals shares in Q4 2022, an estimated $543K.
  • Allspring Global Investments first reported a position in Aerie Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • Allspring Global Investments's Aerie Pharmaceuticals position peaked at $543K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Allspring Global Investments's 13F filing for Q4 2022, filed 23 Jan 2023.